Goto Yasuyuki, Coler Rhea N, Guderian Jeffrey, Mohamath Raodoh, Reed Steven G
Infectious Disease Research Institute, 1124 Columbia St., Suite 400, Seattle, WA 98104, USA.
Infect Immun. 2006 Jul;74(7):3939-45. doi: 10.1128/IAI.00101-06.
Visceral leishmaniasis (VL) is a form of leishmaniasis, which is caused by infection with the protozoan parasite Leishmania, and is often fatal unless it is treated. Rapid and accurate diagnosis of VL is important for effective treatment. Here we report the cloning of previously undescribed tandem repeat (TR) proteins of Leishmania infantum and an evaluation of VL patient antibody responses to the corresponding proteins. By screening an L. infantum expression library with sera from human VL patients or infected hamsters, we identified 43 genes encoding B-cell antigens. Surprisingly, 19 of the 43 genes (44%) were TR proteins, and that percentage was significantly higher than that for genes picked randomly from the database. We then expressed the TR regions of LinJ16.1750, LinJ22.1590, and LinJ33.2870 and the entire LinJ28.2310 protein. These recombinant proteins were all recognized by Sudanese VL patient sera in an enzyme-linked immunosorbent assay. Recombinant LinJ16.1750 (rLinJ16.1750) showed the best performance among these antigens in terms of both sensitivity and specificity. Serological evaluation revealed that 97% (34 of 35) of Sudanese VL patients had significantly elevated antibody levels to rLinJ16.1750. Furthermore, when eight of the patient sera which had low reactivities to rK39 were tested with the novel recombinant antigens, some of the sera showed stronger antibody responses to these antigens than to rK39. Our results suggest that TR regions from the novel L. infantum proteins identified in this study are immunodominant B-cell epitopes and may represent good candidates for serodiagnosis of VL.
内脏利什曼病(VL)是利什曼病的一种形式,由原生动物寄生虫利什曼原虫感染引起,若不治疗往往会致命。快速准确地诊断VL对于有效治疗至关重要。在此,我们报告了婴儿利什曼原虫先前未描述的串联重复(TR)蛋白的克隆以及对VL患者针对相应蛋白的抗体反应的评估。通过用人VL患者或感染仓鼠的血清筛选婴儿利什曼原虫表达文库,我们鉴定出43个编码B细胞抗原的基因。令人惊讶的是,43个基因中有19个(44%)是TR蛋白,该比例显著高于从数据库中随机挑选的基因。然后,我们表达了LinJ16.1750、LinJ22.1590和LinJ33.2870的TR区域以及完整的LinJ28.2310蛋白。在酶联免疫吸附试验中,这些重组蛋白均被苏丹VL患者血清识别。重组LinJ16.1750(rLinJ16.1750)在这些抗原中,在敏感性和特异性方面均表现最佳。血清学评估显示,97%(35例中的34例)的苏丹VL患者对rLinJ16.1750的抗体水平显著升高。此外,当用新型重组抗原检测对rK39反应性较低的8例患者血清时,一些血清对这些抗原的抗体反应比对rK39更强。我们的结果表明,本研究中鉴定出的新型婴儿利什曼原虫蛋白的TR区域是免疫显性B细胞表位,可能是VL血清诊断的良好候选物。